Moving stem cells to the clinic: potential and limitations for brain repair
about
The Preclinical Research Progress of Stem Cells Therapy in Parkinson's DiseaseProgramming and Reprogramming Cellular Age in the Era of Induced PluripotencyWhole-brain 3D mapping of human neural transplant innervation.Stem cell-derived interneuron transplants as a treatment for schizophrenia: preclinical validation in a rodent modelPreclinical Analysis of Fetal Human Mesencephalic Neural Progenitor Cell Lines: Characterization and Safety In Vitro and In Vivo.Functional Connectivity under Optogenetic Control Allows Modeling of Human Neuromuscular Disease.Excessive Wnt/beta-catenin signaling promotes midbrain floor plate neurogenesis, but results in vacillating dopamine progenitors.Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's DiseaseMolecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.Dopamine Receptor Antagonists Enhance Proliferation and Neurogenesis of Midbrain Lmx1a-expressing ProgenitorsStem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.Pluripotent stem cells progressing to the clinic.Intracerebral Cell Implantation: Preparation and Characterization of Cell Suspensions.Adapting Preclinical Benchmarks for First-in-Human Trials of Human Embryonic Stem Cell-Based Therapies.In Vivo Reprogramming for CNS Repair: Regenerating Neurons from Endogenous Glial Cells.Cell-based therapies for the treatment of schizophrenia.Disentangling neural cell diversity using single-cell transcriptomics.Gene Delivery Approaches for Mesenchymal Stem Cell Therapy: Strategies to Increase Efficiency and Specificity.Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brainPriming of the Cells: Hypoxic Preconditioning for Stem Cell TherapyG-Force PD: a global initiative in coordinating stem cell-based dopamine treatments for Parkinson's disease.High Yield of Adult Oligodendrocyte Lineage Cells Obtained from Meningeal Biopsy.Neurology--the next 10 years.Cografting astrocytes improves cell therapeutic outcomes in a Parkinson's disease model.Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation.A Critical Evaluation of the Methodological Obstacles to Translating Cell-Based Research Into an Effective Treatment for People With Parkinson's Disease.Human induced pluripotent stem cell-derived neuronal progenitors are a suitable and effective drug discovery model for neurological mtDNA disorders.Neuronal replacement therapy: previous achievements and challenges ahead.Fast Generation of Functional Subtype Astrocytes from Human Pluripotent Stem CellsCortical Reshaping and Functional Recovery Induced by Silk Fibroin Hydrogels-Encapsulated Stem Cells Implanted in Stroke AnimalsExtracellular Vesicles, Ageing, and Therapeutic Interventions
P2860
Q26744445-11881FC6-1978-4762-97E8-43F0F3A8561BQ27008903-BA389788-EC39-4757-97DC-A4E49197914EQ30835807-0C85B2A2-3C2C-430F-A0D2-50948460DD82Q30837351-81695F76-88E1-434A-B611-1A4163424070Q33722449-BC445570-4E8F-4B1A-9A54-616BA06A334BQ34501054-E30372BC-7689-433B-BCC2-988ADCC8D612Q36248773-A5FEFDF0-E470-4B9B-A31F-40EEBF351332Q36250893-795362B3-D43D-44F3-9CB0-5A349C2B09EDQ36373006-95D1B65A-65B6-4C92-81F3-B89ED58A62AEQ36953951-7E7E575F-5E12-4720-ACB6-E87057410A5AQ37643268-402F0B66-D426-4667-A743-85F605823448Q38747535-FABE9392-8FC8-4E81-BE0A-9254B5BD3450Q38807492-DF12A5A5-CF51-41AB-83FB-18F3E807F46CQ38873789-A4C27BF0-4830-4C1D-A1D0-22A4574A72E1Q38930831-4C517A3F-78DE-4E6A-BA5D-82B680281160Q38932809-76BECCEB-74EA-402F-9C9B-9EC77E2EFCA5Q38939764-0B6C997F-FBBB-4378-BE13-F7DC44630A42Q40080450-32F4B6A0-A3F4-4D41-A891-61D9DA073322Q41634284-52CA8DEA-1AD4-4852-84D8-DA628EA7C35AQ42267329-D2C70209-6568-40AC-93B3-4C8C3CA55697Q42334406-D6957424-ACE9-4CD3-8BCE-DB60631254D9Q42692068-C23263AF-20C1-4788-8F24-73C885C37045Q46374782-9A375428-DFEE-48BC-B0B2-38A956227118Q47262338-0B21BB91-FF69-4848-A065-23D7C35C74A3Q47734532-6FF8E228-768B-458E-99DE-7B26B432B827Q48858846-6C37AB14-FBCF-40F3-ABC4-FB01EABA38FCQ49504590-07DAB797-20D2-45D5-B46D-ACCDBDDF3D49Q52729618-ECECCEB9-6A9D-4D99-9BF8-730CA575D4D6Q57112909-AC684D5F-71F7-4B35-8F5F-F39BD8785A57Q57214366-7D9712D5-D4C3-4D0D-9E1B-EE2AFFA57EEDQ58766798-2BE52EB6-FCD0-48AD-B51F-F39B48CC8305
P2860
Moving stem cells to the clinic: potential and limitations for brain repair
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Moving stem cells to the clinic: potential and limitations for brain repair
@ast
Moving stem cells to the clinic: potential and limitations for brain repair
@en
Moving stem cells to the clinic: potential and limitations for brain repair
@nl
type
label
Moving stem cells to the clinic: potential and limitations for brain repair
@ast
Moving stem cells to the clinic: potential and limitations for brain repair
@en
Moving stem cells to the clinic: potential and limitations for brain repair
@nl
prefLabel
Moving stem cells to the clinic: potential and limitations for brain repair
@ast
Moving stem cells to the clinic: potential and limitations for brain repair
@en
Moving stem cells to the clinic: potential and limitations for brain repair
@nl
P2860
P1433
P1476
Moving stem cells to the clinic: potential and limitations for brain repair
@en
P2093
Julius A Steinbeck
P2860
P304
P356
10.1016/J.NEURON.2015.03.002
P407
P577
2015-04-01T00:00:00Z